Literature DB >> 22146593

Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites.

Andreas Heuer1, Gaynor A Smith, Mariah J Lelos, Emma L Lane, Stephen B Dunnett.   

Abstract

The unilateral 6-hydroxydopamine mouse lesion models of Parkinson's disease have received increasing attention in recent years, but comparison of the different lesion models was largely focused at a histological level. An extensive behavioural comparison between different mouse models on tests of motor function has yet to be carried out, to pin point tests that accurately discriminate between different extents of dopaminergic depletion. In the present study we examine the consequences of injection of the toxin at three sites along the nigrostriatal tract (substantia nigra, medial forebrain bundle, and striatum) on a broad range of simple motor tasks, and on the dopaminergic pathology. All lesion groups demonstrated marked behavioural deficits and displayed distinct profiles of degeneration along the nigrostriatal dopamine pathway. Tests that correlated closely with the level of substantia nigra cell loss included the corridor, cylinder and balance beam tests, the rotarod, inverted cage lid and three types of rotational assessment (spontaneous, amphetamine-induced and apomorphine-induced). Specific tasks are identified which are capable of distinguishing a near-complete lesion, with amphetamine rotation, corridor and cylinder tests showing the highest correlations with levels of nigral cell loss. Performance in the different behavioural tests was associated with distinct profiles of cell loss in the SN and VTA. We provide a comprehensive behavioural assessment of lesion-induced deficits in mouse models of PD, which should facilitate selection of the most appropriate lesion model and most sensitive behavioural tests for use in future studies investigating therapeutic interventions.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22146593     DOI: 10.1016/j.bbr.2011.11.027

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  33 in total

1.  Acetyl-L-Carnitine via Upegulating Dopamine D1 Receptor and Attenuating Microglial Activation Prevents Neuronal Loss and Improves Memory Functions in Parkinsonian Rats.

Authors:  Sonu Singh; Akanksha Mishra; Neha Srivastava; Rakesh Shukla; Shubha Shukla
Journal:  Mol Neurobiol       Date:  2016-12-14       Impact factor: 5.590

2.  Enhancement of polysialic acid expression improves function of embryonic stem-derived dopamine neuron grafts in Parkinsonian mice.

Authors:  Daniela Battista; Yosif Ganat; Abderrahman El Maarouf; Lorenz Studer; Urs Rutishauser
Journal:  Stem Cells Transl Med       Date:  2013-12-05       Impact factor: 6.940

3.  L-DOPA Reverses the Increased Free Amino Acids Tissue Levels Induced by Dopamine Depletion and Rises GABA and Tyrosine in the Striatum.

Authors:  Oscar Solís; Patricia García-Sanz; Antonio S Herranz; María-José Asensio; Rosario Moratalla
Journal:  Neurotox Res       Date:  2016-03-10       Impact factor: 3.911

4.  Post 6-OHDA lesion exposure to stress affects neurotrophic factor expression and aggravates motor impairment.

Authors:  Phumzile Nomfundo Ngema; Musa Vuyisile Mabandla
Journal:  Metab Brain Dis       Date:  2017-03-20       Impact factor: 3.584

Review 5.  Neurotoxin-Induced Rodent Models of Parkinson's Disease: Benefits and Drawbacks.

Authors:  Mohamed El-Gamal; Mohamed Salama; Lyndsey E Collins-Praino; Irina Baetu; Ahmed M Fathalla; Amira M Soliman; Wael Mohamed; Ahmed A Moustafa
Journal:  Neurotox Res       Date:  2021-03-25       Impact factor: 3.911

6.  Npas1+ Pallidal Neurons Target Striatal Projection Neurons.

Authors:  Kelly E Glajch; Daniel A Kelver; Daniel J Hegeman; Qiaoling Cui; Harry S Xenias; Elizabeth C Augustine; Vivian M Hernández; Neha Verma; Tina Y Huang; Minmin Luo; Nicholas J Justice; C Savio Chan
Journal:  J Neurosci       Date:  2016-05-18       Impact factor: 6.167

7.  Chemical Control of Grafted Human PSC-Derived Neurons in a Mouse Model of Parkinson's Disease.

Authors:  Yuejun Chen; Man Xiong; Yi Dong; Alexander Haberman; Jingyuan Cao; Huisheng Liu; Wenhao Zhou; Su-Chun Zhang
Journal:  Cell Stem Cell       Date:  2016-04-28       Impact factor: 24.633

8.  GDNF is not required for catecholaminergic neuron survival in vivo.

Authors:  Jaakko Kopra; Carolina Vilenius; Shane Grealish; Mari-Anne Härma; Kärt Varendi; Jesse Lindholm; Eero Castrén; Vootele Võikar; Anders Björklund; T Petteri Piepponen; Mart Saarma; Jaan-Olle Andressoo
Journal:  Nat Neurosci       Date:  2015-03       Impact factor: 24.884

9.  Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.

Authors:  Richard Gordon; Eduardo A Albornoz; Daniel C Christie; Monica R Langley; Vinod Kumar; Susanna Mantovani; Avril A B Robertson; Mark S Butler; Dominic B Rowe; Luke A O'Neill; Anumantha G Kanthasamy; Kate Schroder; Matthew A Cooper; Trent M Woodruff
Journal:  Sci Transl Med       Date:  2018-10-31       Impact factor: 17.956

10.  Altered biometal homeostasis is associated with CLN6 mRNA loss in mouse neuronal ceroid lipofuscinosis.

Authors:  Katja M Kanninen; Alexandra Grubman; Aphrodite Caragounis; Clare Duncan; Sarah J Parker; Grace E Lidgerwood; Irene Volitakis; George Ganio; Peter J Crouch; Anthony R White
Journal:  Biol Open       Date:  2013-05-20       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.